Pappas Capital LLC
06/24/2011 | Press release | Archived content
Diabetes drug company Lumena raising up to $2M to reach clinical ...
News | 06. 24. 2011
Lumena Pharmaceuticals
June 24, 2011
Diabetes drug development company Lumena Pharmaceuticals aims to harness a benefit that diabetics receive from gastric bypass surgery and deliver it to those patients in the form of a pill.
The Durham, North Carolina-based company plans to start clinical trials on its experimental drug this year. To get there, Lumena has raised $500,000 in a round that could go up to $2 million with funding so far coming largely from Durham venture capital firm Pappas Ventures.
Pappas Capital LLC published this content on June 24, 2011, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 22, 2026 at 10:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]